Blockchain Registration Transaction Record

United Health Products Updates FDA Application and Capital Markets Activities

United Health Products provides a crucial update on FDA application and funding activities, signaling progress towards commercializing its hemostatic agent. Investors and healthcare professionals should take note of UHP's advancements in the medical field.

This news highlights the progress of United Health Products towards conducting a clinical study for its hemostatic agent. The successful approval of its FDA application and funding efforts can potentially lead to the commercialization of CelluSTAT, offering a natural solution for controlling bleeding. Investors and healthcare professionals should closely monitor UHP's developments as it moves closer to accessing the human surgical market.